Login to Your Account



Other News To Note


Thursday, January 20, 2011
Boehringer Ingelheim GmbH, of Ingelheim, Germany, will acquire the rights in and substantially all assets at Amgen Inc.'s, Fremont, Calif., development and manufacturing facility.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription